Acoziborole

CAS number
1266084-51-8
Application
Acoziborole is a novel boron-containing candidate developed as an oral drug for the treatment of human African trypanosomiasis (HAT).
Molecular weight
367.1 g/mol
Molecular formula
C17H14BF4NO3

SOCOSUR OEL/OEB Risk Assessments are a quick and efficient way to obtain:

  • Complete review of all relevant toxicological and medical databases as well as Material Safety Data Sheets and chemical books, in accordance with the regulations from National Institute for Occupational Safety and Health (NIOSH), Naumann and Safebridge
  • A classification in four categories based on CLP Regulation and Naumann and Safebridge proposals
  • A rational for NOAEL values selection
  • Categorization for the specific work conditions

Benefits of such OEL/OEB Assessment

A 20 to 30 pages report signed by an European toxicological expert, optimized in case of Regulatory Body inspection, with all calculation details and all bibliographic references linked to these calculations, as well as all the development and results for the categorization of the product.